PLIANT THERAPEUTICS (PLRX) stock: insider trades, news & valuation
Heavy sellingShare price and insider trades
PLIANT THERAPEUTICS insider trading at a glance (Oct 9, 2026): in the past 12 months, 0 insiders bought $0 and 4 sold $164K of PLRX stock on the open market.
Get emailed when insiders cluster-buy stocks like PLRX
Free alerts the day a new cluster buy is filed, plus the Monday report of the week's biggest insider trades.
Free · unsubscribe anytime · not investment advice · see a sample issue
PLRX insider buying and selling by quarter
Open-market purchases (green, above the line) and sales (red, below), by trade date.
| Quarter | Bought | Purchases | Sold | Sales |
|---|---|---|---|---|
| Q4 2026 | — | 0 | — | 0 |
| Q3 2026 | — | 0 | — | 0 |
| Q2 2026 | — | 0 | — | 0 |
| Q1 2026 | — | 0 | $164K | 4 |
Valuation, profit and volume
Summary
Over the past 12 months, 0 PLIANT THERAPEUTICS, INC. insiders reported open-market purchases totaling $0, while 4 insiders reported sales totaling $164K. 4 of 4 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.
Insider transactions
Open-market purchases and sales.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Jan 22SEC | Bernard CoulieCEO, President | Sell Plan | 89,375505,601 held (−15%) | $1.28 | $114K | -20.3% | — |
| Jan 22SEC | Keith Lamont CummingsCFO | Sell Plan | 24,002297,214 held (−7%) | $1.28 | $31K | -20.3% | — |
| Jan 22SEC | Lily CheungChief Human Resource Officer | Sell Plan | 7,53444,847 held (−14%) | $1.28 | $10K | -20.3% | — |
| Jan 22SEC | Minnie KuoCOO | Sell Plan | 6,91737,806 held (−15%) | $1.28 | $9K | -20.3% | — |
Insiders at PLIANT THERAPEUTICS, INC.
| Insider | Bought | Sold | Last filing | Score |
|---|---|---|---|---|
| Bernard CoulieCEO, President | — | $114K | Jan 22, 2026 | — |
| Keith Lamont CummingsCFO | — | $31K | Jan 22, 2026 | — |
| Lily CheungChief Human Resource Officer | — | $10K | Jan 22, 2026 | — |
| Minnie KuoCOO | — | $9K | Jan 22, 2026 | — |
PLRX stock: common questions
Are PLIANT THERAPEUTICS, INC. insiders buying PLRX stock?
In the past 12 months, 0 insiders reported open-market purchases of PLRX worth $0.
Are PLIANT THERAPEUTICS, INC. insiders selling PLRX stock?
4 insiders reported sales worth $164K over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.
What is PLRX's 52-week range?
Over the past year PLRX has traded between $0.99 and $1.87. It last closed at $1.02 on Oct 9, 2026.